Showing results (631-640 of 694) with videos related to
Sort By:
Pageof 70
Diagnostic Microbiology and Infectious Disease|January 21, 2015
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009Shio-Shin Jean, Wen-Sen Lee, Kuan-Jen Bai, et al.Transplantation Proceedings|October 27, 2021
A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant RecipientWen-Ruei Tang, Che-Wei Hsu, Chia-Chi Lee, et al.Jac-Antimicrobial Resistance|August 30, 2024
Emerging Aspergillus lentulus infections in Taiwan: clinical and environmental surveillancePao-Yu Chen, Chien-Ming Chao, Chwan-Yau Luo, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 2, 2026
Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbationTsunglin Liu, Ching-Han Lai, Yu-Wei Wu, et al.International Journal of Antimicrobial Agents|July 4, 2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)Po-Liang Lu, Yung-Ching Liu, Han-Siong Toh, et al.International Journal of Antimicrobial Agents|July 4, 2012
In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)Yuag-Meng Liu, Yao-Shen Chen, Han-Siong Toh, et al.International Journal of Antimicrobial Agents|July 4, 2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010Chi-Chang Huang, Yao-Shen Chen, Han-Siong Toh, et al.Frontiers in Neurology|March 11, 2021
Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS ExperienceSheng-Feng Lin, Han-Hwa Hu, Bo-Lin Ho, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 17, 2020
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from TaiwanChih-Chao Yang, Long-Sun Ro, Nai-Wen Tsai, et al.Frontiers in Neurology|October 4, 2021
Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS ExperienceSheng-Feng Lin, Han-Hwa Hu, Bo-Lin Ho, et al.Pageof 70